Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Viktor, Bánhegyi"'
Autor:
Kálmán Benke, Viktor Bánhegyi, Edina Korca, Gábor Veres, Yuliana Yakobus, Meradjoddin Matin, Gábor Szabó
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 19, Iss 1, Pp 1-5 (2024)
Abstract Background New prosthetic valves and surgical approaches that shorten operation time and improve the outcome of patients with aortic valve (AV) infective endocarditis (IE) and AV insufficiency (AVI) are crucial. The aim of this study was to
Externí odkaz:
https://doaj.org/article/cffe15149f8b4b54ba935f5e6b027603
Autor:
Mária Lódi, Viktor Bánhegyi, Beáta Bódi, Alexandra Gyöngyösi, Árpád Kovács, Anita Árokszállási, Nazha Hamdani, Miklós Fagyas, István Édes, Zoltán Csanádi, István Czuriga, Zoltán Kisvárday, István Lekli, Péter Bai, Attila Tóth, Zoltán Papp, Dániel Czuriga
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-18 (2020)
Abstract Background Cardiomyopathy is a common side effect of doxorubicin (DOX) chemotherapy. Despite intensive research efforts in the field, there is still no evidence available for routine cardioprotective prophylaxis to prevent cardiotoxicity in
Externí odkaz:
https://doaj.org/article/2ac15617c7aa42b2999a5adb53714ca2
Autor:
David Santer, Felix Nagel, Inês Fonseca Gonçalves, Christoph Kaun, Johann Wojta, Miklós Fagyas, Martin Krššák, Ágnes Balogh, Zoltán Papp, Attila Tóth, Viktor Bánhegyi, Karola Trescher, Attila Kiss, Bruno K. Podesser
Publikováno v:
ESC Heart Failure, Vol 7, Iss 5, Pp 2113-2122 (2020)
Abstract Aims Tenascin‐C (TN‐C) is suggested to be detrimental in cardiac remodelling after myocardial infarction (MI). The aim of this study is to reveal the effects of TN‐C on extracellular matrix organization and its haemodynamic influence i
Externí odkaz:
https://doaj.org/article/91ad737678b74223b8fd980be7256afe
Autor:
Viktor Bánhegyi, Attila Enyedi, Gábor Áron Fülöp, Attila Oláh, Ivetta Mányiné Siket, Csongor Váradi, Klaudia Bottyán, Mária Lódi, Alexandra Csongrádi, Azeem J. Umar, Miklós Fagyas, Dániel Czuriga, István Édes, Miklós Pólos, Béla Merkely, Zoltán Csanádi, Zoltán Papp, Gábor Szabó, Tamás Radovits, István Takács, Attila Tóth
Publikováno v:
Cells, Vol 10, Iss 7, p 1708 (2021)
Objective: Inhibitors of the angiotensin converting enzyme (ACE) are the primarily chosen drugs to treat heart failure and hypertension. Moreover, an imbalance in tissue ACE/ACE2 activity is implicated in COVID-19. In the present study, we tested the
Externí odkaz:
https://doaj.org/article/533fd267c0a748e98c7b9988dae01145
Autor:
Inês Fonseca Gonçalves, Zoltán Papp, D. Santer, Christoph Kaun, Miklós Fagyas, Attila Tóth, Karola Trescher, Ágnes Balogh, F. Nagel, Viktor Bánhegyi, Attila Kiss, Johann Wojta, Bruno K. Podesser, Martin Krššák
Publikováno v:
ESC Heart Failure, Vol 7, Iss 5, Pp 2113-2122 (2020)
Aims Tenascin‐C (TN‐C) is suggested to be detrimental in cardiac remodelling after myocardial infarction (MI). The aim of this study is to reveal the effects of TN‐C on extracellular matrix organization and its haemodynamic influence in an expe
Autor:
Miklós Fagyas, Attila Kertész, Ivetta Siket Mányiné, Viktor Bánhegyi, Bertalan Kracskó, Andrea Szegedi, Miklós Szokol, Gusztáv Vajda, Ildikó Rácz, Zoltán Csanádi, Zoltán Papp, Attila Tóth, Sándor Sipka
Coronavirus disease 2019 (COVID-19) has a high mortality in elderly patients with pre- existing cardiovascular diseases. The cellular receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the angiotensin converting enzyme 2 (ACE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72577997eee245a7c6fe1c8c717ba558
https://doi.org/10.21203/rs.3.rs-34549/v1
https://doi.org/10.21203/rs.3.rs-34549/v1
Autor:
Miklós, Fagyas, Attila, Kertész, Ivetta Mányiné, Siket, Viktor, Bánhegyi, Bertalan, Kracskó, Andrea, Szegedi, Miklós, Szokol, Gusztáv, Vajda, Ildikó, Rácz, Hajnalka, Gulyás, Noémi, Szkibák, Vivienn, Rácz, Zoltán, Csanádi, Zoltán, Papp, Attila, Tóth, Sándor, Sipka
Publikováno v:
GeroScience
Coronavirus disease 2019 (COVID-19) has a high mortality in elderly patients with pre-existing cardiovascular diseases. The cellular receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the angiotensin-converting enzyme 2 (ACE2
Autor:
Gábor Á, Fülöp, Attila, Oláh, Tamas, Csipo, Árpád, Kovács, Róbert, Pórszász, Roland, Veress, Balázs, Horváth, László, Nagy, Beáta, Bódi, Miklós, Fagyas, Solveig Lind, Helgadottir, Viktor, Bánhegyi, Béla, Juhász, Mariann, Bombicz, Daniel, Priksz, Peter, Nanasi, Béla, Merkely, István, Édes, Zoltán, Csanádi, Zoltán, Papp, Tamás, Radovits, Attila, Tóth
Publikováno v:
Basic Research in Cardiology
Omecamtiv mecarbil (OM) is a promising novel drug for improving cardiac contractility. We tested the therapeutic range of OM and identified previously unrecognized side effects. The Ca2+ sensitivity of isometric force production (pCa50) and force at
Autor:
Mária Lódi, Gabor A. Fulop, Alexandra Csongrádi, Nagy Laszlo, Ádám Leskó, Péter P. Nánási, Árpád Kovács, Tamás Csípő, Zoltán Papp, Ildikó Gödény, László Balogh, Beáta Bódi, Viktor Bánhegyi
Publikováno v:
Cardiologia Hungarica. 47:145-152
Autor:
Miklós Fagyas, K Bottyan, Attila Enyedi, I Manyine Siket, Viktor Bánhegyi, I. Édes, Zoltán Papp, Attila Tóth
Publikováno v:
Cardiovascular Research. 114:S139-S139